Real-world effectiveness of psychiatric pharmacotherapies in reducing the risk of substance use- and psychiatric hospitalisations in cannabis use disorder – an exploratory nationwide register-based study
Nationwide register study reveals psychiatric pharmacotherapy associations with reduced hospitalization risk in cannabis use disorder, highlighting targeted medication strategies.
Key Points
To evaluate the real-world effectiveness of psychiatric pharmacotherapies in reducing the risk of substance use- and psychiatric-related hospitalizations in individuals with cannabis use disorder.
Exploratory nationwide register-based cohort study utilizing comprehensive health registry data.
Tracked psychiatric pharmacotherapy exposures and subsequent admissions for substance use and psychiatric hospitalizations.
Evaluated real-world associations between specific psychiatric pharmacotherapies and hospital admission rates in cannabis use disorder.
Identified variations in hospitalization risks according to distinct psychiatric medication regimens across the nationwide cohort.